SKI Market

A+| A| A-|

Indian Indices

Sensex

74,532.96 325.72
( 0.44%)

Global Indices

Nasdaq

45,612.20 -430.24
(-0.93%)

Dow Jones

6,526.68 -100.81
(-1.52%)

Hang Seng

53,297.18 -1,942.22
(-3.52%)

Nikkei 225

9,927.54 -135.96
(-1.35%)

Forex

USD-INR

93.13 0.41
(0.44%)

EUR-INR

107.17 0.41
(0.39%)

GBP-INR

124.14 0.56
(0.45%)

JPY-INR

0.59 0.00
(0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532296

INE935A01035

848.3143291

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLENMARK

41.49

61549.41

EPS(TTM)

Face Value()

Div & Yield %

52.57

0.11

Back

ifgl refractories ltd

NDA Securities reports consolidated net loss of Rs 0.52 crore in the December 2025 quarter

Jan 20,2026

Net loss of NDA Securities reported to Rs 0.52 crore in the quarter ended December 2025 as against net profit of Rs 0.12 crore during the previous quarter ended December 2024. Sales declined 26.67% to Rs 1.21 crore in the quarter ended December 2025 as against Rs 1.65 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1.21	1.65	-27
OPM %	-29.75	16.97	-
PBDT	-0.43	0.20	PL
PBT	-0.46	0.17	PL
NP	-0.52	0.12	PL

74,532.96 325.72 ( 0.44%)

45,612.20 -430.24 (-0.93%)

6,526.68 -100.81 (-1.52%)

53,297.18 -1,942.22 (-3.52%)

9,927.54 -135.96 (-1.35%)

93.13 0.41 (0.44%)

107.17 0.41 (0.39%)

124.14 0.56 (0.45%)

0.59 0.00 (0.73%)